抗 VEGF 治疗改善小鼠同基因胶质母细胞瘤模型中 EGFR-vIII-CAR-T 细胞的递送与疗效
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.
62.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.
Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。